T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Alector
ALEC
$228M
| $18.8M | ﹤0.01% |
1,848,125
-42,783
| -2% | -$427K |
|
1177
Aaon
AAON
$7.23B
| $18.8M | ﹤0.01% |
513,749
-2,317
| -0.4% | -$81.1K |
|
|
ARNC
1178
DELISTED
Arconic Corporation
ARNC
| $18.7M | ﹤0.01% |
667,921
+6,871
| +1% | +$186K |
|
1179
Evertec
EVTC
$1.91B
| $18.7M | ﹤0.01% |
507,813
+78,333
| +18% | +$2.99M |
|
1180
Alpha Metallurgical Resources
AMR
$1.97B
| $18.7M | ﹤0.01% |
144,961
+139,961
| +2,799% | +$21.2M |
|
1181
Sana Biotechnology
SANA
$1.1B
| $18.6M | ﹤0.01% |
2,891,581
+841,448
| +41% | +$5.36M |
|
1182
Chemed
CHE
$7.02B
| $18.6M | ﹤0.01% |
39,532
+2,081
| +6% | +$1.02M |
|
1183
New Oriental
EDU
$8.33B
| $18.5M | ﹤0.01% |
908,721
-969,548
| -52% | -$13.3M |
|
1184
Allegion
ALLE
$14.2B
| $18.5M | ﹤0.01% |
188,899
-5,258
| -3% | -$571K |
|
1185
NetApp
NTAP
$40.2B
| $18.5M | ﹤0.01% |
283,344
-29,782
| -10% | -$2.14M |
|
1186
NerdWallet
NRDS
$639M
| $18.4M | ﹤0.01% |
2,316,221
+49,443
| +2% | +$502K |
|
1187
VF Corp
VFC
$5.79B
| $18.3M | ﹤0.01% |
413,403
-50,007
| -11% | -$2.51M |
|
1188
Synchrony
SYF
$26.1B
| $18.2M | ﹤0.01% |
658,530
-126,825
| -16% | -$4.4M |
|
1189
Xylem
XYL
$28.1B
| $18.1M | ﹤0.01% |
231,508
-22,671
| -9% | -$1.87M |
|
1190
LKQ Corp
LKQ
$6.38B
| $18M | ﹤0.01% |
367,310
-31,416
| -8% | -$1.55M |
|
1191
Healthpeak Properties
DOC
$14.3B
| $18M | ﹤0.01% |
695,782
-71,130
| -9% | -$2.16M |
|
1192
AES
AES
$10.5B
| $18M | ﹤0.01% |
855,918
-79,379
| -8% | -$1.73M |
|
1193
J.M. Smucker
SJM
$12.9B
| $18M | ﹤0.01% |
140,432
-11,338
| -7% | -$1.51M |
|
|
AQUA
1194
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $17.8M | ﹤0.01% |
548,829
+340,029
| +163% | +$12.9M |
|
1195
Coty
COTY
$2.42B
| $17.8M | ﹤0.01% |
2,218,822
+2,069,642
| +1,387% | +$15.5M |
|
1196
UDR
UDR
$12.2B
| $17.7M | ﹤0.01% |
385,071
-30,180
| -7% | -$1.52M |
|
1197
Freshworks
FRSH
$3.51B
| $17.7M | ﹤0.01% |
1,343,910
+506,781
| +61% | +$7.89M |
|
1198
Rollins
ROL
$17.4B
| $17.7M | ﹤0.01% |
505,791
-21,227
| -4% | -$729K |
|
1199
Seagate
STX
$209B
| $17.5M | ﹤0.01% |
245,388
-30,931
| -11% | -$2.51M |
|
1200
Hormel Foods
HRL
$13.4B
| $17.5M | ﹤0.01% |
369,054
-32,480
| -8% | -$1.62M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.